These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1848168)

  • 1. Indocyanine green elimination in patients with liver disease and in normal subjects.
    Burns E; Triger DR; Tucker GT; Bax ND
    Clin Sci (Lond); 1991 Feb; 80(2):155-60. PubMed ID: 1848168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the hepatic extraction ratio of indocyanine green in swine.
    Kisor DF; Frye RF; Kudsk KA
    Clin Sci (Lond); 1993 Jun; 84(6):681-5. PubMed ID: 8334816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
    Ott P; Keiding S; Bass L
    Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and indirect measurement of the hepatic extraction ratio of indocyanine green in the rat.
    Burns E; Ball CE; Christie JP; Broadhead GD; Tucker GT; Bax ND
    Clin Sci (Lond); 1989 May; 76(5):503-8. PubMed ID: 2721117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Beppu T; Sugiura M; Sanjo K; Idezuki Y
    Clin Pharmacol Ther; 1988 Aug; 44(2):217-24. PubMed ID: 3396264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
    Lay CS; Tsai YT; Kong CW; Lee FY; Chang TT; Lin HC; Yang CM; Lee SD; Chiang BN; Lo KJ
    Clin Pharmacol Ther; 1988 Oct; 44(4):453-7. PubMed ID: 3168396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic uptake of indocyanine green and perfusion rate in rats: effect of age and albumin concentration.
    Montgomery PR; Sitar DS
    Can J Physiol Pharmacol; 1988 May; 66(5):592-5. PubMed ID: 3416230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man.
    Grainger SL; Keeling PW; Brown IM; Marigold JH; Thompson RP
    Clin Sci (Lond); 1983 Feb; 64(2):207-12. PubMed ID: 6822056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
    Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
    Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying a long standing error in single-bolus determination of the hepatic extraction ratio for indocyanine green.
    Wissler EH
    Eur J Appl Physiol; 2011 Apr; 111(4):641-6. PubMed ID: 20953795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of dye infusion rate and hepatic plasma flow on indocyanine green clearance.
    Krarup N; Larsen JA
    Scand J Clin Lab Invest; 1976 Mar; 36(2):183-8. PubMed ID: 1273495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of hepatic disease on the disposition of moricizine in humans.
    Pieniaszek HJ; Davidson AF; McEntegart CM; Quon CY; Sampliner RE; Mayersohn M
    Biopharm Drug Dispos; 1994 Apr; 15(3):243-52. PubMed ID: 7880984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bolus and infusion methods for estimating hepatic blood flow in patients with liver disease using indocyanine green.
    Clements D; West R; Elias E
    J Hepatol; 1987 Dec; 5(3):282-7. PubMed ID: 3429835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model.
    Mann DV; Chui AK; Lau WY
    Br J Surg; 2000 Dec; 87(12):1734-5. PubMed ID: 11123166
    [No Abstract]   [Full Text] [Related]  

  • 16. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.
    Pind ML; Bendtsen F; Kallemose T; Møller S
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):948-54. PubMed ID: 27172450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic drug clearance: the effect of age using indocyanine green as a model compound.
    Wynne HA; Goudevenos J; Rawlins MD; James OF; Adams PC; Woodhouse KW
    Br J Clin Pharmacol; 1990 Oct; 30(4):634-7. PubMed ID: 2291878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
    Hashimoto M; Watanabe G
    Hepatogastroenterology; 2000; 47(36):1669-74. PubMed ID: 11149029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose.
    Pollack GM; Brouwer KL; Demby KB; Jones JA
    Drug Metab Dispos; 1990; 18(2):197-202. PubMed ID: 1971573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of continuously infused indocyanine green in the pig.
    Ott P; Bass L; Keiding S
    J Pharmacokinet Biopharm; 1996 Feb; 24(1):19-44. PubMed ID: 8827582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.